{"altmetric_id":8464377,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":90},"news":{"unique_users_count":38,"unique_users":["everyday_health","northwest_indiana_times","medicinenet","business_insider","eurekalert","health_medicinet","medicalxpress","health_day","us_news_health","ehe_me","doctors_lounge","drugs_com","health_news","philly_com","health_finder","lincoln_journal_star","winona_daily_news","billings_gazette","foreign_affairs_new_zealand","physicians_briefing","medlineplus","st_louis_post_dispatch","mpr","today_topics","newsmax_com","the_globe_and_mail","webmd_news","physicians_weekly","medscape","yahoo_news_india","yahoo_news","channel_newsasia","upi_com","arizona_daily_star","fox_news","medpage_today","medical_news_today","science_daily"],"posts_count":76},"blogs":{"unique_users_count":2,"unique_users":[57678,58359],"posts_count":2},"twitter":{"unique_users_count":8,"unique_users":["JAMANetwork","MBHolistic","MeCoffeeBreak","plagiarismfraud","indusinternal","JAMAInternalMed","1MADdoc2b","tx_rockstar"],"posts_count":10},"facebook":{"unique_users_count":2,"unique_users":["147116508633029","114116793520"],"posts_count":2}},"selected_quotes":["JAMA - Notice of Retraction: An article by Sato et al has been retracted. #health #research","Notice of Retraction #internalmedicine"],"citation":{"altmetric_jid":"53bd372b2a83eef6128b4568","authors":["Howard Bauchner","Rita F. Redberg","Bauchner, Howard","Redberg, Rita F"],"doi":"10.1001\/jamainternmed.2016.3177","first_seen_on":"2016-06-03T17:51:21+00:00","funders":["niehs"],"isbns":[],"issns":["2168-6106","2168-6114"],"issue":"9","journal":"JAMA Internal Medicine","last_mentioned_on":1505833453,"links":["http:\/\/archinte.jamanetwork.com\/article.aspx?articleID=2526968&utm_source=dlvr.it&utm_medium=%5Btwitter%5D&utm_campaign=%5Barticle_alert%5D&utm_content=%5Bautomated%5D","http:\/\/archinte.jamanetwork.com\/article.aspx?articleid=2526968","http:\/\/archinte.jamanetwork.com\/article.aspx?articleID=2526968&utm_source=twitterfeed&utm_medium=twitter","http:\/\/archinte.jamanetwork.com\/article.aspx?articleID=2526968","http:\/\/dx.doi.org\/10.1001\/jamainternmed.2016.3177","http:\/\/archinte.jamanetwork.com\/data\/Journals\/INTEMED\/935669\/irt160001.pdf","http:\/\/archinte.jamanetwork.com\/article.aspx?articleid=2526968&utm_source=dlvr.it&utm_medium=%5Btwitter%5D&utm_campaign=%5Barticle_alert%5D&utm_content=%5Bautomated%5D","http:\/\/archinte.jamanetwork.com\/article.aspx?articleid=2526968&utm_source=twitter&utm_medium=social_jamaim&utm_campaign=article_alert&utm_content=automated","http:\/\/archinte.jamanetwork.com\/article.aspx?articleid=2526968&utm_source=facebook&utm_medium=social_jamaim&utm_campaign=article_alert&utm_content=automated","http:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/article-abstract\/2526968"],"pdf_url":"http:\/\/archinte.jamanetwork.com\/data\/Journals\/INTEMED\/0\/irt160001.pdf","pmid":"27258431","pubdate":"2016-06-03T00:00:00+00:00","publisher":"American Medical Association","startpage":"1256","subjects":["internalmedicine"],"title":"\n              Notice of Retraction: Sato Y, et al. The Prevention of Hip Fracture With Risedronate and Ergocalciferol Plus Calcium Supplementation in Elderly Women With Alzheimer Disease: A Randomized Controlled Trial.\n              Arch Intern Med.\n              2005;165(15):1737-1742.\n            ","type":"article","volume":"176","mendeley_url":"http:\/\/www.mendeley.com\/research\/notice-retraction-sato-y-et-al-prevention-hip-fracture-risedronate-ergocalciferol-plus-calcium-suppl"},"altmetric_score":{"score":302.68,"score_history":{"1y":237.04,"6m":8.04,"3m":1,"1m":1,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":302.68},"context_for_score":{"all":{"total_number_of_other_articles":8436356,"mean":7.0937825748122,"rank":20845,"this_scored_higher_than_pct":99,"this_scored_higher_than":8415519,"rank_type":"exact","sample_size":8436356,"percentile":99},"similar_age_3m":{"total_number_of_other_articles":273886,"mean":11.580772849918,"rank":1667,"this_scored_higher_than_pct":99,"this_scored_higher_than":272219,"rank_type":"exact","sample_size":273886,"percentile":99},"this_journal":{"total_number_of_other_articles":2675,"mean":112.57873672401,"rank":247,"this_scored_higher_than_pct":90,"this_scored_higher_than":2428,"rank_type":"exact","sample_size":2675,"percentile":90},"similar_age_this_journal_3m":{"total_number_of_other_articles":152,"mean":221.84067549669,"rank":32,"this_scored_higher_than_pct":78,"this_scored_higher_than":120,"rank_type":"exact","sample_size":152,"percentile":78}}},"demographics":{"poster_types":{"member_of_the_public":6,"practitioner":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":6,"Practitioners (doctors, other healthcare professionals)":1,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Librarian":1},"by_discipline":{"Medicine and Dentistry":1}}},"geo":{"twitter":{"US":6}}},"posts":{"news":[{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28163001336&p=1pl&v=1&x=6d25e_-92J-HezxzNtwM3Q","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T21:47:31+00:00","summary":"Assessment finds 8 in 10 Americans over 60 at risk, a conclusion questioned by several experts.","author":{"name":"Everyday Health","url":"http:\/\/www.everydayhealth.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/470\/normal\/Screen_Shot_2016-01-06_at_14.15.09.png?1452089738"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28163001376&p=1pl&v=1&x=xiyMgTkfnwj_eLcA6eOG1g","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T21:47:31+00:00","summary":"But study wasn't definitive, and heart experts say both newer drugs are better than warfarin.","author":{"name":"Everyday Health","url":"http:\/\/www.everydayhealth.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/470\/normal\/Screen_Shot_2016-01-06_at_14.15.09.png?1452089738"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28166184382&p=1pl&v=1&x=3_w09cgKWbI6rRX-muNa2w","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Northwest Indiana Times","url":"http:\/\/www.nwitimes.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/002\/424\/normal\/Screen_Shot_2016-04-01_at_10.31.38.png?1459503127"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28166184354&p=1pl&v=1&x=aHE9e83Q0gIDTbXpC5BciA","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Northwest Indiana Times","url":"http:\/\/www.nwitimes.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/002\/424\/normal\/Screen_Shot_2016-04-01_at_10.31.38.png?1459503127"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28177644038&p=1pl&v=1&x=NKn7k5uTB3mbjVEPNbFe9g","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-05T07:00:00+00:00","summary":"By Steven Reinberg HealthDay Reporter Latest Heart News MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial\u2026","author":{"name":"Medicinenet","url":"http:\/\/www.medicinenet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/686\/normal\/image.png?1397206938"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28177644065&p=1pl&v=1&x=gpG3Ky-ok0Y19Gekn9SFfw","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-05T07:00:00+00:00","summary":"By Karen Pallarito HealthDay Reporter Latest Diabetes News MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar\u2026","author":{"name":"Medicinenet","url":"http:\/\/www.medicinenet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/686\/normal\/image.png?1397206938"}},{"title":"Risk test may put too many in unhelpful 'prediabetes' category","url":"http:\/\/ct.moreover.com\/?a=28166171393&p=1pl&v=1&x=8XUkqby6MDJCHDVfx-rfbw","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556,12408654],"posted_on":"2016-10-03T18:12:17+00:00","summary":"By Kathryn Doyle (Reuters Health) - A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"Business Insider","url":"http:\/\/www.businessinsider.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/271\/normal\/Screen_Shot_2016-01-06_at_15.23.25.png?1452093826"}},{"title":"Statins associated with lower risk of cardiac events for some patients, not others","url":"http:\/\/ct.moreover.com\/?a=26972326046&p=1pl&v=1&x=5TlFuEf8iX-5LoLsao5pMw","license":"public","citation_ids":[8921758,8921758,8464377,8464304,8769611,8921758],"posted_on":"2016-06-20T04:00:00+00:00","summary":"Cholesterol-lowering statins were associated with lower risk for major cardiac events in some patients with preexisting ischemic heart disease but not in others, according to an article published online by JAMA Internal Medicine.","author":{"name":"EurekAlert!","url":"http:\/\/www.eurekalert.org\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/077\/normal\/image.png?1369859505"}},{"title":"Statins associated with lower risk of cardiac events for some patients, not others","url":"http:\/\/ct.moreover.com\/?a=26972814553&p=1pl&v=1&x=FQghgVP4uIs_JSMUQFatRQ","license":"public","citation_ids":[8921758,8464377,8464304,8769611,8921758],"posted_on":"2016-06-20T16:07:58+00:00","summary":"Cholesterol-lowering statins were associated with lower risk for major cardiac events in some patients with preexisting ischemic heart disease but not in others, according to an article published online by JAMA Internal Medicine.","author":{"name":"Health Medicinet","url":"http:\/\/healthmedicinet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/942\/normal\/image.png?1402915110"}},{"title":"Statins associated with lower risk of cardiac events for some patients, not others","url":"http:\/\/ct.moreover.com\/?a=26973342452&p=1pl&v=1&x=Jd4XYAjxcAieYURrmwEFbA","license":"public","citation_ids":[8921758,8464377,8464304,8769611],"posted_on":"2016-06-20T17:08:52+00:00","summary":"Cholesterol-lowering statins were associated with lower risk for major cardiac events in some patients with preexisting ischemic heart disease but not in others, according to an article published online by JAMA Internal Medicine.","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26975205076&p=1pl&v=1&x=0HQnI6D_yuGqSxg6OuPhCA","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T20:15:37+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Health Day ","url":"http:\/\/consumer.healthday.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/405\/normal\/Screen_Shot_2015-12-10_at_14.19.56.png?1449757216"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26975456241&p=1pl&v=1&x=7Q_7Pa14rv5b9ZtF_lsbZg","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T20:00:00+00:00","summary":"By Alan Mozes HealthDay Reporter MONDAY, June 20, 2016 (HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do\u2026","author":{"name":"US News Health","url":"http:\/\/health.usnews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/826\/normal\/Screen_Shot_2016-01-27_at_10.42.54.png?1453891593"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26975626702&p=1pl&v=1&x=zQ7BJNKg4ofbP4l7DwfXGg","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T21:01:55+00:00","summary":"Driving cholesterol down to very low levels produced no extra benefit By Alan Mozes HealthDay Reporter MONDAY, June 20, 2016 (HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart\u2026","author":{"name":"EHE&ME","url":"http:\/\/www.eheandme.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/834\/normal\/Screen_Shot_2016-01-27_at_11.01.46.png?1453892822"}},{"title":"Just a Little of Statins\u2019 Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26975656544&p=1pl&v=1&x=h5a6VuXzHmNH4oXRp7DcCg","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T21:04:54+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26976066320&p=1pl&v=1&x=Xlkk3dxqv3cQZ3e_BlyXBA","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T16:00:37+00:00","summary":", 2016 -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Drugs.com","url":"http:\/\/www.drugs.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/406\/normal\/Screen_Shot_2016-02-03_at_10.28.55.png?1454495345"}},{"title":"Just a Little of Statins\u2019 Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26976189934&p=1pl&v=1&x=lDAWj3DhqZdwxG5DtUw8PQ","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T19:37:03+00:00","summary":"By Alan Mozes HealthDay Reporter MONDAY, June 20, 2016 (HealthDay News) \u2014 Giving high doses of statins to patients with heart disease doesn\u2019t lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a\u2026","author":{"name":"Health: News","url":"http:\/\/news.health.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/777\/normal\/Screen_Shot_2016-01-26_at_17.03.43.png?1453827857"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26976376434&p=1pl&v=1&x=neEDyfQeTr-VM66ij64nOg","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T20:00:00+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Philly.com","url":"http:\/\/www.philly.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/115\/normal\/image.png?1369925690"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart","url":"http:\/\/ct.moreover.com\/?a=26976916943&p=1pl&v=1&x=6eZgWKJnuFFyP4i7k-N9ew","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T23:26:00+00:00","summary":"Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Everyday Health","url":"http:\/\/www.everydayhealth.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/470\/normal\/Screen_Shot_2016-01-06_at_14.15.09.png?1452089738"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26979353871&p=1pl&v=1&x=gCnOoZumRw4PMIms03BY-w","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T17:00:00+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Health Finder","url":"http:\/\/www.healthfinder.gov","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/895\/normal\/Screen_Shot_2016-01-27_at_14.14.54.png?1453904124"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26979824902&p=1pl&v=1&x=Vh-rvJyTbcrk651t_wwWOQ","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T00:00:00+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Lincoln Journal Star","url":"http:\/\/journalstar.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/217\/normal\/image.png?1370277841"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26979992400&p=1pl&v=1&x=g67eIbWjV_1GSlDk_4BlnA","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T20:00:00+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Winona Daily News","url":"http:\/\/www.winonadailynews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/160\/normal\/image.png?1369927591"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26980462858&p=1pl&v=1&x=Uhr789uNV-jMLIhWUX6X8g","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T20:00:00+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Billings Gazette","url":"http:\/\/billingsgazette.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/436\/normal\/Screen_Shot_2016-01-06_at_12.13.12.png?1452082409"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26980867615&p=1pl&v=1&x=gFHcZPzfjsl5zo8IRpW1vQ","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T20:00:00+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"Northwest Indiana Times","url":"http:\/\/www.nwitimes.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/002\/424\/normal\/Screen_Shot_2016-04-01_at_10.31.38.png?1459503127"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart","url":"http:\/\/ct.moreover.com\/?a=26986249717&p=1pl&v=1&x=Nkff_A87OtYhdI630HR55w","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-21T15:50:09+00:00","summary":"MIL OSI \u2013 Source: US Government \u2013 Health Info and News \u2013 Press Release\/Statement: Headline: Just a Little of Statins\u2019 Effect Enough to Help Heart MONDAY, June 20, 2016 (HealthDay News) \u2014 Giving high doses of statins to patients with heart disease\u2026","author":{"name":"Foreign Affairs New Zealand","url":"http:\/\/foreignaffairs.co.nz\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/827\/normal\/Screen_Shot_2016-01-27_at_10.47.41.png?1453891760"}},{"title":"Moderately Low LDL May Be Enough to Ward Off CVD Risk","url":"http:\/\/ct.moreover.com\/?a=26986351587&p=1pl&v=1&x=6d8CLDrlkzDdmqi0I7URvg","license":"public","citation_ids":[8921758,8921758,8925707,8464377,8464304,8769611],"posted_on":"2016-06-21T16:06:50+00:00","summary":"(HealthDay News) -- Very low target low-density lipoprotein (LDL) cholesterol levels may not benefit all patients with preexisting heart disease, according to a study published online June 20 in JAMA Internal Medicine.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study: MedlinePlus","url":"http:\/\/ct.moreover.com\/?a=26986383187&p=1pl&v=1&x=G8hQ5unKkmUOcNw_lM2jOQ","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-20T20:00:00+00:00","summary":"MONDAY, June 20, 2016 (HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"MedlinePlus","url":"https:\/\/medlineplus.gov\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/363\/normal\/Screen_Shot_2016-02-02_at_16.40.46.png?1454431260"}},{"title":"Moderately Low LDL May Be Enough to Ward Off CVD Risk","url":"http:\/\/ct.moreover.com\/?a=26987006543&p=1pl&v=1&x=Tp4SfMOric5LfY0epcLdhg","license":"public","citation_ids":[8921758,8921758,8925707,8464377,8464304,8769611],"posted_on":"2016-06-21T17:07:39+00:00","summary":"(HealthDay News) -- Very low target low-density lipoprotein (LDL) cholesterol levels may not benefit all patients with preexisting heart disease, according to a study published online June 20 in JAMA Internal Medicine.","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26988149185&p=1pl&v=1&x=c0mWGVrjI4ikTG-lQMkpxw","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-21T19:00:10+00:00","summary":"(HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol-lowering drugs do, a new study finds.","author":{"name":"St. Louis Post-Dispatch","url":"http:\/\/www.stltoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/574\/normal\/Screen_Shot_2016-01-06_at_17.19.29.png?1452100790"}},{"title":"LDL Targets May Need Reevaluation for Some CVD Patients, Study Finds","url":"http:\/\/ct.moreover.com\/?a=26988293466&p=1pl&v=1&x=_Fee8Q7D5k0NAfDemNp9Hg","license":"public","citation_ids":[8921758,8921758,8925707,8464377,8464304,8769611],"posted_on":"2016-06-21T19:14:04+00:00","summary":"Researchers find reduction to 70 mg\/dL range not associated with additional benefit HealthDay News \u2014 Very low target low-density lipoprotein (LDL) cholesterol levels may not benefit all patients with preexisting heart disease, according to a study\u2026","author":{"name":"MPR","url":"http:\/\/www.empr.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/567\/normal\/image.png?1392205523"}},{"title":"Just a Little of Statins' Effect Enough to Help Heart: Study","url":"http:\/\/ct.moreover.com\/?a=26993564876&p=1pl&v=1&x=0aNKbctAdCqJ6_qIZgmvIQ","license":"public","citation_ids":[8464377,8464304,8769611],"posted_on":"2016-06-22T07:00:00+00:00","summary":"By Alan Mozes HealthDay Reporter Latest Heart News MONDAY, June 20, 2016 (HealthDay News) -- Giving high doses of statins to patients with heart disease doesn't lower the risk of future heart trouble any more than moderate doses of the cholesterol -lo\u2026","author":{"name":"Medicinenet","url":"http:\/\/www.medicinenet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/686\/normal\/image.png?1397206938"}},{"title":"Statins associated with lower risk of cardiac events for some patients, not others","url":"http:\/\/feedproxy.google.com\/~r\/healthtopicstoday\/~3\/OeTK9oO0adI\/","license":"public","citation_ids":[8921758,8921758,8464377,8464304,8769611],"posted_on":"2016-06-22T11:25:02+00:00","summary":"Cholesterol-lowering statins were associated with lower risk for major cardiac events in some patients with preexisting ischemic heart disease but not in others, according to an article published online by JAMA Internal Medicine.","author":{"name":"Today Topics ","url":"http:\/\/www.todaytopics.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/290\/normal\/Screen_Shot_2014-11-27_at_12.02.15.png?1417089747"}},{"title":"Risk test may put too many in unhelpful 'prediabetes' category","url":"http:\/\/ct.moreover.com\/?a=28161335475&p=1pl&v=1&x=7DouSvx7nWub1v3s2y8EUw","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556,12408654],"posted_on":"2016-10-03T18:02:17+00:00","summary":"By Kathryn Doyle (Reuters Health) - A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"Philly.com","url":"http:\/\/www.philly.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/115\/normal\/image.png?1369925690"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28161568516&p=1pl&v=1&x=6fmacaYoinSRv0XjNVm7NQ","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T00:00:00+00:00","summary":"By Steven Reinberg HealthDay Reporter MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new\u2026","author":{"name":"US News Health","url":"http:\/\/health.usnews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/826\/normal\/Screen_Shot_2016-01-27_at_10.42.54.png?1453891593"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28161568522&p=1pl&v=1&x=osDXJEODEgm1ah9Rsud1gQ","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T00:00:00+00:00","summary":"By Karen Pallarito HealthDay Reporter MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new\u2026","author":{"name":"US News Health","url":"http:\/\/health.usnews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/826\/normal\/Screen_Shot_2016-01-27_at_10.42.54.png?1453891593"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28161754466&p=1pl&v=1&x=8vfX7p4lWg8oGppwhgpcEA","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T19:05:24+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Health Day ","url":"http:\/\/consumer.healthday.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/405\/normal\/Screen_Shot_2015-12-10_at_14.19.56.png?1449757216"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28161754471&p=1pl&v=1&x=5g9xM5NsPfJO6z3B15wqAg","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T19:05:24+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Health Day ","url":"http:\/\/consumer.healthday.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/405\/normal\/Screen_Shot_2015-12-10_at_14.19.56.png?1449757216"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28161840014&p=1pl&v=1&x=YH9ZGt0ZWODTV2U3kWC-AA","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T19:16:03+00:00","summary":"Assessment finds 8 in 10 Americans over 60 at risk, a conclusion questioned by several experts By Karen Pallarito HealthDay Reporter MONDAY, Oct.","author":{"name":"EHE&ME","url":"http:\/\/www.eheandme.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/834\/normal\/Screen_Shot_2016-01-27_at_11.01.46.png?1453892822"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28161860798&p=1pl&v=1&x=yraM7As4C9bOrsfDunWKuw","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T19:18:53+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28161860799&p=1pl&v=1&x=7ILW02O9g_jMZnaAVVC_bA","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T19:18:53+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}},{"title":"Test May Label Too Many 'Prediabetic'","url":"http:\/\/ct.moreover.com\/?a=28162021760&p=1pl&v=1&x=uibvphwpFs-1sEQk-3mlOA","license":"public","citation_ids":[8464377,8464304,12405556,12408654,12403623,12405556],"posted_on":"2016-10-03T19:39:23+00:00","summary":"A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"newsmax.com","url":"http:\/\/www.newsmax.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/354\/normal\/Screen_Shot_2015-04-07_at_17.01.46.png?1428422529"}},{"title":"Online \u2018risk test\u2019 may put too many in prediabetes category: study","url":"http:\/\/www.theglobeandmail.com\/life\/health-and-fitness\/health\/online-risk-test-may-put-too-many-in-prediabetes-category-study\/article32215313\/?cmpid=rss1","license":"public","citation_ids":[8464377,8464304,12405556,12408654,12403623,12405556],"posted_on":"2016-10-03T19:53:16+00:00","summary":"A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"The Globe and Mail","url":"http:\/\/www.theglobeandmail.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/017\/normal\/the_globe_and_mail.png?1369846906"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28162422463&p=1pl&v=1&x=lKyJQjkiYSXV2zg0uITV6g","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T20:32:27+00:00","summary":"But study wasn't definitive, and heart experts say both newer drugs are better than warfarin By Steven Reinberg HealthDay Reporter MONDAY, Oct.","author":{"name":"EHE&ME","url":"http:\/\/www.eheandme.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/834\/normal\/Screen_Shot_2016-01-27_at_11.01.46.png?1453892822"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28162520802&p=1pl&v=1&x=y2ryAcc1ZpJKXgjPIfjGhw","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Philly.com","url":"http:\/\/www.philly.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/115\/normal\/image.png?1369925690"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28162520816&p=1pl&v=1&x=yOk-r3BxjNIjYyuFKDCe-w","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Philly.com","url":"http:\/\/www.philly.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/115\/normal\/image.png?1369925690"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28162631893&p=1pl&v=1&x=0pFBHpZCaQ4VNLwCpvi6ng","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T14:10:07+00:00","summary":"MONDAY, Oct. 3, 2016 -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Drugs.com","url":"http:\/\/www.drugs.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/406\/normal\/Screen_Shot_2016-02-03_at_10.28.55.png?1454495345"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28162631882&p=1pl&v=1&x=_kL4_ebX85NwBWGLmncUpQ","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T14:10:45+00:00","summary":"MONDAY, Oct. 3, 2016 -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Drugs.com","url":"http:\/\/www.drugs.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/406\/normal\/Screen_Shot_2016-02-03_at_10.28.55.png?1454495345"}},{"title":"Risk test may put too many in unhelpful \u2018prediabetes\u2019 category","url":"http:\/\/ct.moreover.com\/?a=28162790077&p=1pl&v=1&x=sBdZu8GL9W-79a0m3K1ZHA","license":"public","citation_ids":[8464377,8464304,12405556,12408654,12403623,12405556],"posted_on":"2016-10-03T21:15:05+00:00","summary":"(Reuters Health) \u2013 A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"Health Medicinet","url":"http:\/\/healthmedicinet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/942\/normal\/image.png?1402915110"}},{"title":"Test May Label Too Many \u2018Prediabetic\u2019","url":"http:\/\/ct.moreover.com\/?a=28163712581&p=1pl&v=1&x=PcZoEpLEMj3l90eaXgDZIA","license":"public","citation_ids":[8464377,8464304,12405556,12408654,12403623,12405556],"posted_on":"2016-10-03T23:16:19+00:00","summary":"A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"Health Medicinet","url":"http:\/\/healthmedicinet.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/942\/normal\/image.png?1402915110"}},{"title":"Researchers Question Value of Web-Based Test for Prediabetes","url":"http:\/\/ct.moreover.com\/?a=28164273362&p=1pl&v=1&x=Etf35aMJPjUiavdgJP107Q","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556],"posted_on":"2016-10-04T00:55:23+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up testing, according to a research letter published online Oct.","author":{"name":"Physician's Briefing","url":"http:\/\/www.physiciansbriefing.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/372\/normal\/logo.png?1436525474"}},{"title":"Researchers Question Value of Web-Based Test for Prediabetes","url":"http:\/\/ct.moreover.com\/?a=28164351175&p=1pl&v=1&x=oYsJYxL4VTIDkY09jUm7-w","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556],"posted_on":"2016-10-04T01:07:02+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up testing, according to a research letter published online Oct.","author":{"name":"Doctors Lounge","url":"http:\/\/www.doctorslounge.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/301\/normal\/Screen_Shot_2016-02-02_at_15.39.07.png?1454427565"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28166309051&p=1pl&v=1&x=tjX_Bce8v4rbOyAkFQ7Olw","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T20:15:10+00:00","summary":"By Steven Reinberg HealthDay Reporter MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new\u2026","author":{"name":"WebMD News","url":"http:\/\/www.webmd.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/049\/normal\/image.png?1369859983"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28166361896&p=1pl&v=1&x=x1j5dM4TXI_xo-CC--HLzA","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-04T06:19:31+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"St. Louis Post-Dispatch","url":"http:\/\/www.stltoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/574\/normal\/Screen_Shot_2016-01-06_at_17.19.29.png?1452100790"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28166361912&p=1pl&v=1&x=qnAcJuMRp0Sy-ETyV1l-yg","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-04T06:19:31+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"St. Louis Post-Dispatch","url":"http:\/\/www.stltoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/574\/normal\/Screen_Shot_2016-01-06_at_17.19.29.png?1452100790"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28166716580&p=1pl&v=1&x=cbPdevcM1dz6enipfGstMQ","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Winona Daily News","url":"http:\/\/www.winonadailynews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/160\/normal\/image.png?1369927591"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28166716594&p=1pl&v=1&x=OhcAOR7MT5eiOa8d1n9lfg","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Winona Daily News","url":"http:\/\/www.winonadailynews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/160\/normal\/image.png?1369927591"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28167289118&p=1pl&v=1&x=iOLbiSJzim7KrH02ruieYA","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Billings Gazette","url":"http:\/\/billingsgazette.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/436\/normal\/Screen_Shot_2016-01-06_at_12.13.12.png?1452082409"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28167289125&p=1pl&v=1&x=4rM-upIE_Hjn935zgYqD0g","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Billings Gazette","url":"http:\/\/billingsgazette.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/436\/normal\/Screen_Shot_2016-01-06_at_12.13.12.png?1452082409"}},{"title":"Researchers Question Value of Web-Based Test for Prediabetes","url":"http:\/\/ct.moreover.com\/?a=28170285607&p=1pl&v=1&x=wnHXKAoaXPQM-Ae_uHtvXg","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556],"posted_on":"2016-10-03T04:00:00+00:00","summary":"Advertisement MONDAY, Oct. 3, 2016 (HealthDay News) \u2014 A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up testing, according to a research letter published online Oct.","author":{"name":"Physician's Weekly","url":"http:\/\/www.physiciansweekly.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/553\/normal\/Screen_Shot_2016-01-06_at_16.43.49.png?1452098646"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28170720812&p=1pl&v=1&x=eUe68ZIh8fM_fMilH18d2Q","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Lincoln Journal Star","url":"http:\/\/journalstar.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/217\/normal\/image.png?1370277841"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28170720864&p=1pl&v=1&x=bmXEoOhX3OUIIhjklzQejA","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T18:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Lincoln Journal Star","url":"http:\/\/journalstar.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/217\/normal\/image.png?1370277841"}},{"title":"Researchers question value of web-based test for prediabetes","url":"http:\/\/ct.moreover.com\/?a=28171133562&p=1pl&v=1&x=UBjV1_7j4AlrQnqYX1ZZrg","license":"public","citation_ids":[8464377,8464304,12405556,12403623,12405556],"posted_on":"2016-10-04T15:25:20+00:00","summary":"(HealthDay)\u2014A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up testing, according to a research letter published online Oct.","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"Is Web-Based Test Labeling Too Many People With 'Prediabetes'?","url":"http:\/\/ct.moreover.com\/?a=28193391378&p=1pl&v=1&x=iFaHhAGM17GCN6iwMEmLBQ","license":"public","citation_ids":[12403623,12405556,3714691,8464377,8464304,12403623,12405556],"posted_on":"2016-10-06T14:07:32+00:00","summary":"New research shows that a majority of US adults over age 40 are at risk for prediabetes, according to an online risk calculator, but the investigators question whether so many people should receive the diagnosis.","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}},{"title":"Is Web-Based Test for Prediabetes Faulty?: MedlinePlus Health News","url":"http:\/\/ct.moreover.com\/?a=28172412416&p=1pl&v=1&x=y2b8MuOd0V9Mjbjl7Ioewg","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-04T17:44:03+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"MedlinePlus","url":"https:\/\/medlineplus.gov\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/363\/normal\/Screen_Shot_2016-02-02_at_16.40.46.png?1454431260"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa: MedlinePlus Health News","url":"http:\/\/ct.moreover.com\/?a=28172412407&p=1pl&v=1&x=zbIf0osnK-zlpsNOHXmjxA","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-04T17:44:03+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"MedlinePlus","url":"https:\/\/medlineplus.gov\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/363\/normal\/Screen_Shot_2016-02-02_at_16.40.46.png?1454431260"}},{"title":"Fewer Major Bleeds on Dabigatran vs Rivaroxaban for AF","url":"http:\/\/ct.moreover.com\/?a=28174225715&p=1pl&v=1&x=mqMAYgc6FkZTGd8ebC5V4g","license":"public","citation_ids":[12405074,12408654,8464377,8464304,12408654],"posted_on":"2016-10-04T21:31:19+00:00","summary":"Reuters Health Information By Reuters Staff | October 04, 2016 NEW YORK (Reuters Health) - In elderly patients with nonvalvular atrial fibrillation (AF), dabigatran and rivaroxaban provide comparable protection against thromboembolic stroke but\u2026","author":{"name":"Medscape","url":"http:\/\/medscape.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/055\/normal\/medscape.png?1369846939"}},{"title":"CardioBrief: More Bleeds With Rivaroxaban in Real-World Comparison","url":"http:\/\/ct.moreover.com\/?a=28186643611&p=1pl&v=1&x=8OTeM1qxRxaWzackC9Oz1A","license":"public","citation_ids":[12405074,12408654,8464377,8464304,10892274,12408654,12405074],"posted_on":"2016-10-05T23:45:29+00:00","summary":"Patients who take rivaroxaban ( Xarelto ) may be more likely to have serious bleeding events than patients who take dabigatran ( Pradaxa ), an observational study found.","author":{"name":"Everyday Health","url":"http:\/\/www.everydayhealth.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/470\/normal\/Screen_Shot_2016-01-06_at_14.15.09.png?1452089738"}},{"title":"Risk test may put too many in unhelpful 'prediabetes' category","url":"http:\/\/ct.moreover.com\/?a=28161371914&p=1pl&v=1&x=pVqWuhr0BoKeKet4EE732Q","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556,12408654],"posted_on":"2016-10-03T18:12:17+00:00","summary":"By Kathryn Doyle (Reuters Health) - A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"Yahoo! News India","url":"http:\/\/in.news.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/422\/normal\/Screen_Shot_2016-02-02_at_14.59.50.png?1454425204"}},{"title":"Risk test may put too many in unhelpful 'prediabetes' category","url":"http:\/\/ct.moreover.com\/?a=28161484410&p=1pl&v=1&x=0tjdUtCg_ve5oCSxZWSWXw","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556,12408654],"posted_on":"2016-10-03T18:12:17+00:00","summary":"By Kathryn Doyle (Reuters Health) - A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"Yahoo! News","url":"http:\/\/news.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/032\/normal\/yahoo_news.png?1369846922"}},{"title":"Risk test may put too many in unhelpful 'prediabetes' category","url":"http:\/\/ct.moreover.com\/?a=28161499873&p=1pl&v=1&x=in7lrhDO2oMarkFuAqi-4Q","license":"public","citation_ids":[12403623,12405556,8464377,8464304,12405556,12408654],"posted_on":"2016-10-03T18:15:29+00:00","summary":"(Reuters Health) - A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"Channel NewsAsia","url":"http:\/\/www.channelnewsasia.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/527\/normal\/Screen_Shot_2016-01-12_at_14.40.15.png?1452609632"}},{"title":"Some increased bleeding risk seen with blood thinner Xarelto vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28162053638&p=1pl&v=1&x=cN9ersdsoEpoiXJTt5DHGQ","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T19:43:14+00:00","summary":"MONDAY, Oct. 3, 2016 -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"UPI.com","url":"http:\/\/upi.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/057\/normal\/upi_com.png?1369846942"}},{"title":"Some Increased Bleeding Risk Seen With Blood Thinner Xarelto Vs. Pradaxa","url":"http:\/\/ct.moreover.com\/?a=28166024470&p=1pl&v=1&x=eq6dlqKXlmpJFD0tJuvhzA","license":"public","citation_ids":[8464377,8464304,12405556],"posted_on":"2016-10-03T00:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- The blood thinner Xarelto may pose a slightly greater risk of serious bleeding than Pradaxa in patients with the abnormal heartbeat known as atrial fibrillation, new research suggests.","author":{"name":"Arizona Daily Star","url":"http:\/\/tucson.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/270\/normal\/Screen_Shot_2016-01-12_at_14.20.34.png?1452608450"}},{"title":"Is Web-Based Test for Prediabetes Faulty?","url":"http:\/\/ct.moreover.com\/?a=28166024474&p=1pl&v=1&x=D5D_xxUjrxY0Ogjdbb1zYA","license":"public","citation_ids":[8464377,8464304,12405556,12541951],"posted_on":"2016-10-03T00:00:00+00:00","summary":"MONDAY, Oct. 3, 2016 (HealthDay News) -- A simple, seven-question test for prediabetes may be needlessly sending millions of healthy Americans to their physicians for follow-up blood sugar testing, a new analysis suggests.","author":{"name":"Arizona Daily Star","url":"http:\/\/tucson.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/270\/normal\/Screen_Shot_2016-01-12_at_14.20.34.png?1452608450"}},{"title":"Risk Test May Put Too Many In Unhelpful 'Prediabetes' Category","url":"http:\/\/ct.moreover.com\/?a=28170022372&p=1pl&v=1&x=ZeI4ffUbKg-87uSLkOGZBw","license":"public","citation_ids":[8464377,8464304,12405556,12408654,12403623,12405556],"posted_on":"2016-10-04T12:28:00+00:00","summary":"A widely supported web-based risk test suggests that 8 out of 10 people aged 60 years and older in the U.S.","author":{"name":"FOX News","url":"http:\/\/www.foxnews.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/026\/normal\/fox_news.png?1369846915"}},{"title":"CardioBrief: More Bleeds With Rivaroxaban in Real-World Comparison","url":"http:\/\/ct.moreover.com\/?a=28182022482&p=1pl&v=1&x=4b55zIM3Flb8iDGD9vAvsA","license":"public","citation_ids":[12405074,12408654,8464377,8464304,10892274,12408654,12405074],"posted_on":"2016-10-05T14:27:09+00:00","summary":"Patients who take rivaroxaban (Xarelto) may be more likely to have serious bleeding events than patients who take dabigatran (Pradaxa), an observational study found.","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}},{"title":"Statins associated with lower risk of cardiac events for some patients, not others","url":"http:\/\/ct.moreover.com\/?a=26997840409&p=1pl&v=1&x=_lv4FyiFN4e7fh3PGcQK0g","license":"public","citation_ids":[8921758,8921758,8464377,8464304,8769611],"posted_on":"2016-06-22T11:00:00+00:00","summary":"Cholesterol-lowering statins were associated with lower risk for major cardiac events in some patients with preexisting ischemic heart disease but not in others, according to an article published online by JAMA Internal Medicine.","author":{"name":"Medical News Today","url":"http:\/\/www.medicalnewstoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/040\/normal\/medical_news_today.png?1369846932"}},{"title":"Statins associated with lower risk of cardiac events for some patients, not others","url":"http:\/\/ct.moreover.com\/?a=26985051912&p=1pl&v=1&x=-tAXi1XSCgITrzXTy00Q4g","license":"public","citation_ids":[8464377,8464304,8769611,8921758,8921758],"posted_on":"2016-06-20T15:59:38+00:00","summary":"Cholesterol-lowering statins were associated with lower risk for major cardiac events in some patients with preexisting ischemic heart disease but not in others, according to an article published online by JAMA Internal Medicine.","author":{"name":"Science Daily","url":"http:\/\/www.sciencedaily.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/179\/normal\/image.png?1369927053"}}],"twitter":[{"url":"http:\/\/twitter.com\/JAMANetwork\/statuses\/738790120870924288","license":"gnip","citation_ids":[8464377],"posted_on":"2016-06-03T17:51:05+00:00","author":{"name":"The JAMA Network","image":"https:\/\/pbs.twimg.com\/profile_images\/2151337984\/jamanetwork3_normal.png","id_on_source":"JAMANetwork","tweeter_id":"404920570","geo":{"lt":null,"ln":null},"followers":428},"tweet_id":"738790120870924288"},{"url":"http:\/\/twitter.com\/MBHolistic\/statuses\/738809573729927169","license":"gnip","citation_ids":[8464377],"posted_on":"2016-06-03T19:08:23+00:00","author":{"name":"Monterey Holistic","url":"http:\/\/www.montereybayholistic.com","image":"https:\/\/pbs.twimg.com\/profile_images\/793206537254686724\/_c1aiyQP_normal.jpg","description":"501(c)3 #health #education #exercise #healthnews #nutrition #holistic #fitness #wellness #inspirational #healing #success #quotes #yoga #chiropractic #fitness","id_on_source":"MBHolistic","tweeter_id":"28173797","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":28320},"tweet_id":"738809573729927169"},{"url":"http:\/\/twitter.com\/MeCoffeeBreak\/statuses\/738809581871206400","license":"gnip","rt":["MBHolistic"],"citation_ids":[8464377],"posted_on":"2016-06-03T19:08:25+00:00","author":{"name":"Taylor","url":"http:\/\/facebook.com\/allamerican1776","image":"https:\/\/pbs.twimg.com\/profile_images\/693857490858020864\/BINUARFu_normal.jpg","description":"#BYOB #Coffee. We provide the ambiance... open 24hrs","id_on_source":"MeCoffeeBreak","tweeter_id":"551930905","geo":{"lt":35.50069,"ln":-80.00032,"country":"US"},"followers":3801},"tweet_id":"738809581871206400"},{"url":"http:\/\/twitter.com\/plagiarismfraud\/statuses\/739876733441056769","license":"gnip","citation_ids":[8464304,8464377],"posted_on":"2016-06-06T17:48:54+00:00","author":{"name":"\u30df\u30b9\u30b3\u30f3\u30fb\u30d7\u30ec\u30a4 \u7814\u7a76\u4e0d\u6b63\u30fb\u76d7\u7528","url":"http:\/\/twilog.org\/plagiarismfraud","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"\u7814\u7a76\u4e0d\u6b63 misconduct\u3001\u8ad6\u6587\u76d7\u7528 plagiarism\u3001\u634f\u9020 fabrication \u3001\u6539\u3056\u3093 falsification \u306a\u3069\u3002","id_on_source":"plagiarismfraud","tweeter_id":"3415962746","geo":{"lt":null,"ln":null},"followers":202},"tweet_id":"739876733441056769"},{"url":"http:\/\/twitter.com\/indusinternal\/statuses\/739880050678484993","license":"gnip","citation_ids":[8464377],"posted_on":"2016-06-06T18:02:05+00:00","author":{"name":"Internal Medicine","url":"http:\/\/bit.ly\/carlorajmd","image":"https:\/\/pbs.twimg.com\/profile_images\/707054223700193281\/WcOC10Bz_normal.jpg","description":"Facilitating the latest in #InternalMedicine for our growing #MedEd community. #USMLE Curated & Moderated by @CarloRajMD.","id_on_source":"indusinternal","tweeter_id":"3063190467","geo":{"lt":26.35869,"ln":-80.0831,"country":"US"},"followers":515},"tweet_id":"739880050678484993"},{"url":"http:\/\/twitter.com\/JAMANetwork\/statuses\/774642105243152387","license":"gnip","citation_ids":[8464377],"posted_on":"2016-09-10T16:14:04+00:00","author":{"name":"The JAMA Network","image":"https:\/\/pbs.twimg.com\/profile_images\/2151337984\/jamanetwork3_normal.png","id_on_source":"JAMANetwork","tweeter_id":"404920570","geo":{"lt":null,"ln":null},"followers":428},"tweet_id":"774642105243152387"},{"url":"http:\/\/twitter.com\/JAMAInternalMed\/statuses\/777516062023622657","license":"gnip","citation_ids":[8464377],"posted_on":"2016-09-18T14:34:09+00:00","author":{"name":"JAMAInternalMed","url":"http:\/\/jamainternalmed.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/3050584576\/b864c8572e31e8e60e5d6c374d427c44_normal.png","description":"JAMA Internal Medicine is an international peer-reviewed journal published weekly online and monthly in print.","id_on_source":"JAMAInternalMed","tweeter_id":"54664757","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":41327},"tweet_id":"777516062023622657"},{"url":"http:\/\/twitter.com\/1MADdoc2b\/statuses\/777516569555562497","license":"gnip","rt":["JAMAInternalMed"],"citation_ids":[8464377],"posted_on":"2016-09-18T14:36:10+00:00","author":{"name":"Madelyn Corkern","image":"https:\/\/pbs.twimg.com\/profile_images\/752177579927429120\/vU8mHkHV_normal.jpg","id_on_source":"1MADdoc2b","tweeter_id":"63953005","geo":{"lt":29.94687,"ln":-90.32313,"country":"US"},"followers":75},"tweet_id":"777516569555562497"},{"url":"http:\/\/twitter.com\/tx_rockstar\/statuses\/777520308475400193","license":"gnip","rt":["JAMAInternalMed"],"citation_ids":[8464377],"posted_on":"2016-09-18T14:51:01+00:00","author":{"name":"transplantrockstar","image":"https:\/\/pbs.twimg.com\/profile_images\/726805634943967232\/RXRn_izB_normal.jpg","description":"liver recipient (autoimmune hepatitis), 2\/18\/2011. US Masters Swimmer. anonymous donor died 2\/17\/11. thank you. this is for us.","id_on_source":"tx_rockstar","tweeter_id":"4782847254","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":709},"tweet_id":"777520308475400193"},{"url":"http:\/\/twitter.com\/plagiarismfraud\/statuses\/910157588414611461","license":"gnip","citation_ids":[8464377],"posted_on":"2017-09-19T15:04:13+00:00","author":{"name":"\u30df\u30b9\u30b3\u30f3\u30fb\u30d7\u30ec\u30a4 \u7814\u7a76\u4e0d\u6b63\u30fb\u76d7\u7528","url":"http:\/\/twilog.org\/plagiarismfraud","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"\u7814\u7a76\u4e0d\u6b63 misconduct\u3001\u8ad6\u6587\u76d7\u7528 plagiarism\u3001\u634f\u9020 fabrication \u3001\u6539\u3056\u3093 falsification \u306a\u3069\u3002","id_on_source":"plagiarismfraud","tweeter_id":"3415962746","geo":{"lt":null,"ln":null},"followers":202},"tweet_id":"910157588414611461"}],"blogs":[{"title":"JAMA journals pull 3 papers by same authors for misconduct","url":"http:\/\/retractionwatch.com\/2016\/06\/03\/jama-journals-pull-3-papers-by-same-authors-for-misconduct\/","license":"public","citation_ids":[8464998,530762,8464304,8465000,8464377,8465001,4011229,4038626,4705938],"posted_on":"2016-06-03T17:13:00+00:00","summary":"JAMA and another journal in its network have retracted three 2005 papers about preventing hip fractures, after an admission of scientific misconduct.&nbsp; All papers are being retracted over concerns about data integrity, and &ldquo;inappropriate assignme","author":{"name":"Retraction Watch","url":"https:\/\/retractionwatch.com\/","description":"Tracking retractions as a window into the scientific process"}},{"title":"Fraud by bone researcher takes down two meta-analyses, a clinical trial, and review","url":"http:\/\/retractionwatch.com\/2017\/04\/18\/fraud-bone-researcher-takes-two-meta-analyses-clinical-trial-review\/","license":"public","citation_ids":[18532047,19773628,18532047,21700408,19773522,19773520,19568891,9956059,8464304,9956059,8464377,8510813,21700412],"posted_on":"2017-04-18T15:30:00+00:00","summary":"The troubles continue for a bone researcher, who&rsquo;s lost multiple papers in recent months due to problems ranging from data issues to including authors without their consent. Now, journals have retracted two more papers by Yoshihiro Sato. And in a sig","author":{"name":"Retraction Watch","url":"http:\/\/www.retractionwatch.com\/","description":"Tracking retractions as a window into the scientific process"}}],"facebook":[{"title":"Notice of Retraction","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1309885432356125&id=147116508633029","license":"public","citation_ids":[8464377],"posted_on":"2016-09-07T07:28:27+00:00","summary":"A rare retraction of articles purporting to show benefit of risedronate on hip fractures. How many other clinical trials were similarly tainted?","author":{"name":"The Truth About Statins","url":"https:\/\/www.facebook.com\/147116508633029","facebook_wall_name":"The Truth About Statins","image":"https:\/\/graph.facebook.com\/147116508633029\/picture","id_on_source":"147116508633029"}},{"title":"Notice of Retraction","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10155407764153521&id=114116793520","license":"public","citation_ids":[8464377],"posted_on":"2016-09-18T14:34:15+00:00","summary":"An article by Sato et al has been retracted.","author":{"name":"JAMA Internal Medicine","url":"https:\/\/www.facebook.com\/114116793520","facebook_wall_name":"JAMA Internal Medicine","image":"https:\/\/graph.facebook.com\/114116793520\/picture","id_on_source":"114116793520"}}]}}